Skip to main content
. Author manuscript; available in PMC: 2010 Mar 17.
Published in final edited form as: Arch Neurol. 2009 Feb;66(2):250–254. doi: 10.1001/archneurol.2008.552

Table 3.

Follow-up of High-Density Genomewide Association Findings (Except for APOE-Related Findings) Among Informative Familiesa

NIMH
NIA
NCRAD
CAG
Combined
Gene or Locus (SNP), Trait Model P
Value
No. of
Families
P
Value
No. of
Families
P
Value
No. of
Families
P
Value
No. of
Families
P
Valueb
No. of
Families
GAB2 (rs7101429), affection
 All Additive .005 144 .26 111 .02 93 .21 51 .002 399
 APOE ε4 positive Additive .008 111 .19 92 .04 82 .18 33 .003 318
 APOE ε4 negative Additive .17 33 .74c 18 .20 11 .44 18 .34 80
GOLM1 (rs7019241), affection Dominant .09 86 .96c 73 .37 74 .16 28 .24 261
GWA_15q21 (rs10519262), age at onsetd Recessive .60c 175 .29 156 .20 132 .69c 78 .49 541
GWA_9p24 (rs9886784), affection Recessive .72c 156 .29 131 .75c 117 .05 69 .30 473

Abbreviations: CAG, Consortium on Alzheimer’s Genetics11; NCRAD, National Cell Repository for Alzheimer’s Disease (http://www.ncrad.org); NIA, National Institute on Aging (http://www.ncrad.org); NIMH, National Institute of Mental Health12; SNP, single-nucleotide polymorphism.

a

All P values are 1-tailed.

b

Combined probability test by Fisher.15

c

Transmission of minor allele is opposite to that in the original publication; P value is expressed as 1 − P.

d

Calculated based on the FBAT-LOGRANK statistic in PBAT (http://www.biostat.harvard.edu/~clange/default.htm).